| Application no. and date | 16873468.9 (espacenet) (Federated) (European Patent Register), 20161209 | | Patent/reg. no. and date | DK/EP 3386947, 20210519 | | Publication date | 20181017 | | Priority no. and date | SE 1551615, 20151209 | | EP pub. no. and date |
EP 3386947 20181017 | | Effective date | | | Applicant/owner | Oasmia Pharmaceutical AB, Vallongatan 1
752 28 Uppsala, SE | | Applicant ref. no. | P76921DK01 | | Inventor | BABROU, Dzianis, Stigbergsplan 3
752 28 Uppsala, SE,
BUDNIKAVA, Maryna, Stigbergsplan 3
752 28 Uppsala, SE,
BJÖRKLUND, Mikael, Tinghögsgatan 9
753 34 Uppsala, SE,
ALEKSOV, Julian, Herserudsvägen 14 A
181 50 Lidingö, SE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07C 403/20 (2006.01) , C07D 301/00 (2006.01) , C07D 301/32 (2006.01) , C07D 303/46 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF N-RETINOYLAMINOALKANSULFONSYRE | | Int. application no. | SE2016051238 | | Int. publication no. | WO2017099662 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
